Frist Thomas F III reported other involving 555,500 shares of HCA Healthcare, Inc. at $503.53 for −$280M on Nov 4, 2026

Other
Form 4 code J. Other acquisition or disposition. The filer must describe the transaction.
Director
DIR
Filed Nov 6, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$279,708,137.50Shares × reported price
Shares traded
555,500Common Stock, par value $0.01 per share
Price per share
$503.53Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
32,282,889Indirect · By Hercules Holding II
Trade date
Nov 4, 2026Other
Filed
Nov 6, 2026, 6:04 PM ET2-day reporting delay
Accession
0001140361-26-042525Code J · Transaction 395265
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 4, 2026Other555,500$503.53$279,708,137.50Trade 395266
2 transaction rows in this filing. Joint filers share the same rows.

Filing warnings

Notes recorded with this filing
1 warning
ambiguous transaction codeThe transaction code is missing or represents other activity; review the filing and footnotes.

HCA price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
HCA · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −12%1w ago −12%1d ago −6.5%
Returns since7d +0.8%30d90d180d1y

Footnotes in full

F1: Hercules Holding II ("Hercules") holds 32,282,889 shares of Common Stock, par value $0.01 per share ("Shares"), of HCA Healthcare, Inc. (the "Issuer"). Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to exercise voting and investment control over the Shares held by Hercules, but disclaims beneficial ownership of such Shares except to the extent of his pecuniary interest therein, which may be deemed to include indirect interests in Shares through ownership of Hercules partnership units to the extent of: 3,034,522 Shares by the Reporting Person; 9,497 Shares by the Reporting Person's spouse; and 3,965,851 Shares by trusts for the benefit of the Reporting Person's children of which the Reporting Person or his spouse is trustee. F2: This number represents restricted share units payable in Shares, which will be delivered to the Reporting Person on the date he ceases to be a director of the Issuer. F3: Frisco Holding II ("Frisco") holds 36,557,141 Shares. Frisco is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to exercise voting and investment control over the Shares held by Frisco, but disclaims beneficial ownership of such Shares except to the extent of his pecuniary interest therein, which may be deemed to include indirect interests in Shares through ownership of Frisco partnership units to the extent of: 1,172 Shares by the Reporting Person; and 11,868,140 Shares by trusts for the benefit of the Reporting Person's children of which the Reporting Person or his spouse is trustee. F4: On November 4, 2026, the Reporting Person transferred a total 555,500 units of Hercules to trusts for the benefit of the Reporting Person's children of which the Reporting Person or his spouse is trustee in satisfaction of obligations. Each of these transfers was made at a price per unit of Hercules equal to $503.525 (the average of the high and low prices of the Shares on November 4, 2026). In each case, these transfers did not change the total number of Shares of which the Reporting Person may be deemed to have beneficial ownership.